Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.
Inman, Brant A
Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. [electronic resource] - The Journal of urology May 2006 - 1960; author reply 1960-1 p. digital
Publication Type: Comment; Comparative Study; Letter
0022-5347
10.1016/S0022-5347(05)00970-5 doi
Adjuvants, Immunologic--administration & dosage
BCG Vaccine--administration & dosage
Disease Progression
Humans
Neoplasm Recurrence, Local--prevention & control
Neoplasm Staging
Prospective Studies
Randomized Controlled Trials as Topic
Urinary Bladder Neoplasms--drug therapy
Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. [electronic resource] - The Journal of urology May 2006 - 1960; author reply 1960-1 p. digital
Publication Type: Comment; Comparative Study; Letter
0022-5347
10.1016/S0022-5347(05)00970-5 doi
Adjuvants, Immunologic--administration & dosage
BCG Vaccine--administration & dosage
Disease Progression
Humans
Neoplasm Recurrence, Local--prevention & control
Neoplasm Staging
Prospective Studies
Randomized Controlled Trials as Topic
Urinary Bladder Neoplasms--drug therapy